Boehringer Ingelheim Vetmedica Acquires Licensing Rights for Artilysin(R) Technology from Lysando AG

General Press Releases Wednesday August 13, 2014 14:56
REGENSBURG, Germany--(BUSINESS WIRE)--Aug. 12, 2014

Artilysin(R), a new and innovative technological approach in the fight against pathogenic and multi-resistant bacteria, developed by the research & development company Lysando, has arrived in the pharmaceutical industry. Boehringer Ingelheim Vetmedica has secured the licensing rights for the technology platform Artilysin(R). The company is hopeful to receive significant momentum and solutions from this new substance class for the problem of multi-resistant bacteria, which also is an increasing threat to the animal world.

Artilysin(R)s are proteins that, through a physical mechanism, selectively eliminate pathogenic, multi-resistant and persisting bacteria. By way of license, Boehringer Ingelheim Vetmedica is taking advantage of the possibilities presented by this technology. The scope of applications for Artilysin(R)s spans from human and animal medicine to the food industry and the area of hygiene. They work quickly and with their “friend or foe” identification very specifically and are completely biodegradable. Additionally, no resistances occurred during the expansive studies. Multi-resistant bacteria pose a significant threat to health due to the increasing ineffectiveness of antibiotics. The EU Commission estimates the annual number of deaths caused by multi-resistant bacteria at 25,000. Massive economic effects are linked to this fact.

The Boehringer Ingelheim Group is among the 20 leading pharmaceutical companies worldwide. Their focus areas include research & development, production and marketing of new medicines with significant therapeutic benefits for human and animal health. In 2013, Boehringer Ingelheim reported revenues of appr. 14.1 bn Euros.

Lysando itself is not a manufacturer of pharmaceutical products nor will it become one in the future; it only provides its new technology platform through licensing. "The acquisition of licensing rights for the Artilysin(R) technology by Boehringer Ingelheim Vetmedica is a decisive step in the acceptance of this new class of substances“, explains Markus Matuschka v. Greiffenclau, CEO of Lysando AG.

About Lysando:

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin(R)s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this new technology platform, drugs and substances against pathogenic gram-negative and gram-positive bacteria can be specifically developed, both for antibiotic-resistant and persisting bacteria. With Artilysin(R)s, Lysando has created an effective alternative to antibiotics.

CONTACT:
Press Contact:
WBCO Public Relations & Business Communications GmbH
Frank Wollstein
Tel.: +49-(0)-69 / 133-880-36
Fax: +49-(0)-69 / 133-880-33
Email: f.woellstein@wbco.de

Latest Press Release

GAC Motor Unveils a New Model and Hosts International Distributor Conference During Auto Shanghai 2019

GAC Motor, China's leading automaker, is debuting its all-new GA6, a sedan that features upgraded design, comfort, smart technology, driving control, and safety at the 18th Shanghai International Automobile Industry Exhibition (Auto Shanghai 2019),...

The Belt and Road Shaanxi Xi#an (Samsung)-2019 City Wall International Marathon takes place in Xi#an, China

"The Belt and Road" Shaanxi Xi'an (Samsung)-2019 City Wall International Marathon kicked off in Xi'an, Shaanxi province, China at 8:30 a.m. on April 20, 2019, bringing together 5,000 runners from 28 countries and regions worldwide, including Britain,...

Savor the two alternative choices of Combo Set in Japanese style at Tsubohachi

Tsubohachi presents you special Combo Set for Japanese food lovers to enjoy scrumptious menus. The first set is Combo Set X2 for 2 persons and includes menus like, Ishikari Nabe (Small), the delicious local hot pot in Hokkaido in miso flavored salmon...

WHITE ASPARAGUS FEATURED ON MENU AT FIREPLACE GRILL AND BAR, INTERCONTINENTAL BANGKOK

White asparagus is in season in Germany, and Fireplace Grill and Bar at InterContinental Bangkok is featuring this prized delicacy throughout April and May. Austrian Chef Sebastian Reischer is serving white asparagus poached, sauteed or grilled, with...

Style Follow Skinable Set to Release in Thailand

"Style Follow Skinable", a beauty product created through a partnership between TheHan Co., Ltd. and the well-known, beauty-fashion talk show namesake, "SBS Style Follow", will be launched in Thailand soon, and new products will be added as well. TheHan...

Related Topics